Gerard Silvestri to Risk Assessment
This is a "connection" page, showing publications Gerard Silvestri has written about Risk Assessment.
Connection Strength
1.096
-
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021 11; 160(5):e427-e494.
Score: 0.122
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.112
-
Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
Score: 0.106
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.098
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.090
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.083
-
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015 Feb; 147(2):295-303.
Score: 0.078
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.078
-
Selection criteria for lung-cancer screening. N Engl J Med. 2013 Feb 21; 368(8):728-36.
Score: 0.068
-
Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg. 2008 Jan; 85(1):224-30.
Score: 0.048
-
Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest. 2005 Dec; 128(6):3975-84.
Score: 0.041
-
Lung Cancer Screening Rates During the COVID-19 Pandemic. Chest. 2022 02; 161(2):586-589.
Score: 0.031
-
Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Chest. 2021 11; 160(5):1959-1980.
Score: 0.031
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.022
-
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC Pulm Med. 2016 Jan 22; 16:16.
Score: 0.021
-
Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
Score: 0.019
-
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014 Dec; 11(12):e1001764.
Score: 0.019
-
American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012 Dec; 142(6):1620-1635.
Score: 0.017
-
Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg. 2008 Jul; 86(1):220-6; discussion 227.
Score: 0.012